| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5945449 | DIALYSIS SUPS | Sterile bicarbonate concentrate |
Oct, 2017
(6 years ago) | |
Normocarb Hf 35 is owned by Dialysis Sups.
Normocarb Hf 35 contains Magnesium Chloride; Sodium Bicarbonate; Sodium Chloride.
Normocarb Hf 35 has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Normocarb Hf 35 are:
- US5945449
Normocarb Hf 35 was authorised for market use on 26 July, 2006.
Normocarb Hf 35 is available in solution;injection dosage forms.
Normocarb Hf 35 can be used as use as replacement solution, hemofiltration solution or hemodiafiltration solution in continuous renal replacement therapy.
The generics of Normocarb Hf 35 are possible to be released after 31 October, 2017.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| Orphan Drug Exclusivity(ODE) | Jul 26, 2013 |
Drugs and Companies using MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE ingredient
Market Authorisation Date: 26 July, 2006
Treatment: Use as replacement solution, hemofiltration solution or hemodiafiltration solution in continuous renal replacement therapy
Dosage: SOLUTION;INJECTION
NORMOCARB HF 35 family patents
